Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

CTBC: "Softly This Hand-Crafted News Reaches the Fresh Leaves" - Liu Qiyu

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

CTBC Financial Holding / Equity Capital Markets

<p>After the market close today, <a href="https://www.smartkarma.com/entities/436" target="_blank" data-smartkarma-citation="entities:436:1">Ctbc Financial Holding Co Ltd (2891 TT)</a> 's shareholder Morgan Stanley Formosa is selling 280m shares worth USD200m. In this insight, we will look at the recent performance of the CTBC and score the deal in our ECM Framework. </p><h2>Placement Specifics</h2><ul>
<li>Placement specifics</li>
<li>Company Name: CTBC Financial Holding Co Ltd</li>
<li>Ticker: 2891 TT Equity</li>
<li>Secondary offering &amp; Secondary Placement</li>
<li>Settlement date:25 Jan, 2018</li>
<li>Bookrunner: MS</li>
<li>Indicative deal price: 20.85-21.15</li>
<li>Last Traded Price…</li>
</ul>

After the market close today, Ctbc Financial Holding Co Ltd (2891 TT) 's shareholder Morgan Stanley Formosa is selling 280m shares worth USD200m. In this insight, we will look at the recent performance of the CTBC and score the deal in our ECM Framework. Placement Specifics
Placement specifics
Company Name: CTBC Financial Holding Co Ltd
Ticker: 2891 TT Equity
Secondary offering &amp; Secondary Placement
Settlement date:25 Jan, 2018
Bookrunner: MS
Indicative deal price: 20.85-21.15
Last Traded Price…


CTBC Placement: Strong Price Momentum and a Small Deal